Oscotec Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oscotec inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oscotec Inc Today - Breaking & Trending Today

FDA Grants ODD to Cevidoplenib for the Treatment of Immune Thrombocytopenia

The orphan drug designation (ODD) comes after positive results from a phase 2 trial that showed cevidoplenib improved platelet counts by 63.6% and 40.9% in 2 different dose groups. ....

Taeyoung Yoon , Oscotec Inc , Patients With Persistent , Chronic Immune Thrombocytopenia , Orphan Drug Designation , Oscotec Announces Topline Results ,